Arca Biopharma | ABIO - Beneficio Bruto En Ventas

Precio De Mercado
41.25
Cambio Diario
2.34 6.01%
Mensual
16.00%
Anual
233.74%
Q1 Expectativa
37.74




Beneficio Bruto En Ventas Cambio Fecha
Amgen USD 6.48B 307M 2025-09
Arca Biopharma 0 0 2025-03
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Capricor Therapeutics 11.13M 8.87M 2024-12
Cipla INR 41.64B 6.31B 2025-12
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Cytokinetics USD 17.76M 15.82M 2025-12
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Laboratory Of America USD 993.2M 31.9M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Otsuka Holdings JPY 457.41B 28.26B 2025-12
Pfizer USD 3.54B 7.61B 2025-09
United Therapeutics USD 315.5M 286.6M 2025-12